156 related articles for article (PubMed ID: 12183430)
1. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor.
Cheung ST; Chen X; Guan XY; Wong SY; Tai LS; Ng IO; So S; Fan ST
Cancer Res; 2002 Aug; 62(16):4711-21. PubMed ID: 12183430
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
[TBL] [Abstract][Full Text] [Related]
3. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules.
Hsu HC; Chiou TJ; Chen JY; Lee CS; Lee PH; Peng SY
Hepatology; 1991 May; 13(5):923-8. PubMed ID: 1851494
[TBL] [Abstract][Full Text] [Related]
4. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis.
Ng IO; Guan XY; Poon RT; Fan ST; Lee JM
J Pathol; 2003 Mar; 199(3):345-53. PubMed ID: 12579536
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
8. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
9. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer.
Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M
Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
11. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
13. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
[TBL] [Abstract][Full Text] [Related]
14. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome.
Katoh H; Shibata T; Kokubu A; Ojima H; Loukopoulos P; Kanai Y; Kosuge T; Fukayama M; Kondo T; Sakamoto M; Hosoda F; Ohki M; Imoto I; Inazawa J; Hirohashi S
J Hepatol; 2005 Nov; 43(5):863-74. PubMed ID: 16139920
[TBL] [Abstract][Full Text] [Related]
15. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
[TBL] [Abstract][Full Text] [Related]
16. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
17. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
[TBL] [Abstract][Full Text] [Related]
18. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
[TBL] [Abstract][Full Text] [Related]
20. Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma.
Iizuka N; Tamesa T; Sakamoto K; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2006 Nov; 16(5):1137-42. PubMed ID: 17016605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]